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Background: Fibrosing mediastinitis (FM) is an idiosyncratic reaction to infection with Histoplasma capsulatum with
a prevalence of 3:100,000 people infected. The rarity of post-histoplasmosis fibrosing mediastinitis (PHFM) in areas
where H. capsulatum is endemic suggests that an abnormal immunological host response may be responsible for
the development of fibrosis. Our group previously reported an association between subjects with PHFM and human
leukocyte antigen (HLA)-A*02. We sought to confirm or extend those findings with application of high resolution
HLA typing in a cohort of subjects with PHFM.
Methods: High-resolution HLA typing was performed on DNA samples from a new cohort 34 patients with PHFM.
Control cohorts included 707 subjects from the “European American” subset of the National Marrow Donor Program®
(NMDP) and 700 subjects from Dialysis Clinic, Inc. (DCI). The carriage frequencies of the HLA alleles identified in the
PHFM, NMDP, and DCI cohorts were calculated and then all were compared.
Results: We found an increase in the carriage frequency of HLA-DQB1*04:02 in PHFM subjects relative to the controls
(0.15 versus 0.07 in DCI and 0.05 in NMDP; p = 0.08 and 0.03). Multiple logistic regression showed that DQB1*04:02 was
statistically significant (p = 0.04), while DQB1*03:02 and C*03:04 had point estimates of OR > 1, though they did not
reach statistical significance. The HLA-A*02 association was not replicated.
Conclusions: HLA-DQB1*04:02 is associated with PHFM, which supports the premise that an aberrant host immune
response contributes to the development of PHFM.
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Fibrosing mediastinitis (FM) is characterized by exces-
sive proliferation of invasive fibrous tissue within the
mediastinum. In North America the vast majority of cases
of FM result from an idiosyncratic reaction to infection
with H. capsulatum, a dimorphic fungus endemic to the
Mississippi and Ohio River valleys in the United States, as
well as temperate zones worldwide [1-4]. Other causes of
FM are seen very rarely, including an idiopathic form some-
times associated with retroperitoneal fibrosis, IgG4-related
disease, or medication (methysergide) toxicity [1-3,5].* Correspondence: stephen.b.strock@vanderbilt.edu
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unless otherwise stated.Infection with H. capsulatum is usually asymptomatic
and inconsequential, but in some individuals acute histo-
plasmosis may cause malaise, fever, and cough. A few
patients with acute histoplasmosis develop symptomatic
mediastinal adenitis, often in the subcarinal or right
paratracheal area, with a characteristic central chest pain
worse during inspiration. Acute mediastinal adenitis is
the origin of subsequent unique mediastinal complica-
tions, including mediastinal granuloma and FM. Medias-
tinal granuloma describes a mass, often large (>4 cm), of
coalescent lymph nodes in which a thin capsule contains
semiliquid contents, and is usually asymptomatic.
In contrast, post-histoplasmosis fibrosing mediastinitis
(PHFM) is solid, with dense and invasive fibrosis. The fi-
brous proliferative mass contains ectopic calcification onThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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“concrete,” arising from encircling lymph nodes that
were the site of remote mediastinal adenitis. Its clinical
consequences are due to invasion of normal mediastinal
structures such as the pulmonary vasculature, the super-
ior vena cava, or the airways in any combination [1-3,6].
A typical presentation is auto-amputation of the right
pulmonary artery; obstruction of vessels of both lungs is
less common, but the mortality is high. The diagnosis of
PHFM is based on clinical and radiographic findings as
above, as well as the exclusion of malignancy, radiation
therapy, or thromboembolic disease [1]. This rare com-
plication of histoplasmosis has an observed prevalence
of 3 per 100,000 cases [7]. Although nearly everyone
who lives in an endemic region is infected with H. cap-
sulatum intermittently, it is unclear why some individ-
uals rarely develop PHFM, and suggests a possible
abnormal immunological host response to infection.
The genes encoding the HLA system are located on
chromosome 6. The HLA class I (HLA-A, −B, −C) mol-
ecules are present on most somatic cells, whereas the
HLA class II (HLA-DM, −DO, −DP, −DQ, −DR) mole-
cules are typically expressed by antigen presenting cells.
Both classes are important for antigen processing and
presentation as part of the adaptive immune system
[8,9].
Our group previously reported an association between
subjects with PHFM and the HLA class I molecule,
HLA-A*02. We sought to confirm or extend those find-
ings with application of high resolution HLA typing in a
cohort of subjects with PHFM, as high resolution typing
may be more useful than low resolution typing for the
determination of likely causative genes rather than
linked variations [10]. There are differences in peptide
specificity of HLA subtypes, which potentially corres-
pond to different disease phenotypes [11,12]. Our hy-
pothesis is that an intrinsic inherited characteristic,
represented by HLA type, predisposes individuals to ex-




We recruited 34 consecutive patients with a diagnosis of
PHFM who presented to the Vanderbilt University Med-
ical Center between 2011 and 2013. PHFM was defined
clinically as excessive proliferation of fibrous tissue
within the mediastinum causing invasion of normal me-
diastinal structures. The typical calcifications seen within
the invasive fibrous tissue on chest radiography helped
delineate PHFM from other mediastinal abnormalities
[3]. All patients had serology or imaging that confirmed
prior histoplasmosis [1]. Patients with a history of medi-
astinal radiation therapy or malignancy involving themediastinum were excluded. None of the patients in this
study had increased serum IgG4 levels, although it was
not clinically tested in all patients [5]. Given the genetic
diversity seen between different ethnic groups, we se-
lected only case subjects of European ancestry as deter-
mined by self-report. Other covariates were also
collected, including: age, gender, geographic location,
anatomic structures involved, clinical outcome, and co-
morbid conditions.
Population control subjects
Population controls were obtained from the NMDP,
which has made high-resolution haplotype frequencies
from 21 detailed population categories available (http://
bioinformatics.nmdp.org). For our population control,
we used the data from only the “European American”
subset from 2012-present, consisting of 707 subjects.
HLA carriage frequencies were available at the group
level, but not at the individual level.
Another set of population controls was obtained from
DCI Laboratory in Nashville, TN, which is the local
HLA laboratory for transplant programs. We queried for
results from 2012 – present, resulting in 700 cases. Eth-
nicity of these controls is not available, but HLA carriage
frequencies were available at the individual level. We did
not screen either of our population controls for evidence
of histoplasmosis or PHFM.
HLA genotyping of PHFM patients
High-resolution four-digit typing of the HLA Class I
(HLA-A, −B, −C) and HLA Class II (HLA-DRB1, DQB1,
DQA1, DP, DR3, DR4 and DR5) loci was performed on
DNA samples using the 454 Roche DNA pyrosequencer
with GS FLX chemistry (Roche 454 FLX technology)
utilizing liquid handling robotics and a local database
tracking system. Briefly, multiplex identifier primers tar-
geting exons 2 and 3, containing the peptide determin-
ing regions, were used to amplify each locus separately
and then pooled. HLA allele genotypes were analyzed
for each individual and assigned based on the HLA allele
sequences in the immunogenetics information system
database (http://www.imgt.org).
Statistical methods
This is a case–control study. Standard epidemiological
methods for analyzing case–control data were utilized
[13]. For each allele, the carriage frequencies were com-
pared between FM cases and controls using a chi-
squared test. Multiple logistic regressions were used to
analyze multiple loci simultaneously and this is the pri-
mary analysis [13,14]. However, with a total of 34 FM
cases, the model is limited to be able to include only
three loci at a time without over fitting.
Table 2 Logistic regression with C*03:04, DQB1*03:02,
DQB1*04:02 in the model
Odds ratio estimates
Effect Point estimate 95% Wald confidence limits p-value
C*03:04 1.670 0.718 3.886 0.23
DQB1*03:02 1.971 0.860 4.514 0.11
DQB1*04:02 2.836 1.030 7.809 0.044
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Of the 34 patients, 21 were male and 13 were female.
All were Caucasian. The mean age (± SEM) at the time
of diagnosis of PHFM was 41.2 ± 10.1 years. Table 1
shows the summary data for the group.
The carriage frequencies of the HLA alleles in the
PHFM cohort were calculated and compared to corre-
sponding frequencies determined in the DCI and the
NMDP control cohorts. We found a significant increase
in the carriage frequency of HLA-DQB1*03:02 in the
PHFM cohort relative to controls (0.32 versus 0.18 in
both control cohorts; p = 0.04). Similarly, there was an
increase in the frequency of HLA-DQB1*04:02 in sub-
jects with PHFM relative to the control cohorts (0.15
versus 0.07 in DCI controls and 0.05 in NMDP controls;
p = 0.08 and 0.03). There was a borderline association
between HLA-C*03:04 and PHFM (carriage frequency of
0.29 versus 0.16 in both control cohorts; p = 0.06 and
0.05). The HLA-A*02 association from the 2000 study
was not replicated, as there was no significant difference
in the carrier frequency compared to both control co-
horts (0.50 versus 0.47 in DCI controls and 0.50 in
NMDP controls) [4].
A multiple logistic regression with HLA-C*03:04,
HLA-DQB1*03:02, and HLA-DQB1*04:02 in the model
was conducted. The odds ratios for these factors are re-
ported in Table 2. Among the three factors, HLA-
DQB1*04:02 was statistically significant (p = 0.044) and
the other two had a point estimate of OR greater than 1,
though they did not reach statistical significance.
The HLA-DQB1*03:02 allele is in strong linkage dis-
equilibrium with HLA-DRB1*04:01, but in this study
there was no association between PHFM and HLA-
DRB1*04:01 (carriage frequency of 0.23 versus 0.15 in
DCI controls and 0.17 in NMDP controls; p = 0.24 and
0.37). The HLA-C*03:04 is not in strong linkage disequi-
librium with either of the two HLA-DQB1 alleles in-
creased in the PHFM cohort in Caucasian populations
(www.allelefrequencies.net) and may reflect different ef-
fects. However, in the 10 individuals carrying the HLA-
C*03:04 allele, six also carried HLA-DQB1*03:02 and of
these six individuals four also carried HLA-B*15:01,
which is an extended haplotype combination observed at
low frequency in some European populations (www.allele
frequencies.net). In this study, HLA-B*15:01 is not as-
sociated with PHFM (carriage frequency of 0.14 versusTable 1 Baseline characteristics of the study patients
Gender Male: 21 patients (61%) Female: 13 patients (39%)
Age 41.2 ± 10.1 years
Geographic
location
AL, CA, GA, IA, IL, IN, KY, MI, MO, MS, OH, TN, TX, VA
Anatomic site
involved
Unilateral: 18 (53%) Bilateral: 16 (47%)0.15 in DCI controls and 0.13 in NMDP controls; p =
1.00 and p = 0.80).
Discussion
FM is the most serious late complication of infection
with H. capsulatum. Only a small minority of all individ-
uals infected with H. capsulatum go on to develop
PHFM, so it has long been suspected that these patients
have some unique predisposition. Our hypothesis is that
an intrinsic inherited characteristic, related to HLA type,
predisposes individuals to excessive host reaction to
histoplasmosis, manifested clinically as PHFM.
As has now been established for many autoimmune
and infectious diseases, genetic variation at the HLA loci
is a primary determinant of genetic risk – an observation
that has persisted into the era of genome-wide association
studies. Examples of diseases that have been associated
with HLA molecules include: ankylosing spondylitis with
HLA-B*27; type 1 autoimmune hepatitis with HLA-
DRB1*03:01 and HLA-DRB1*04:01; insulin-dependent
type 1 diabetes mellitis and celiac disease with HLA-
DQB1*03:02; primary biliary cirrhosis, neuromyelitis
optica, and cervical cancer with HLA-DQB1*04:02; and
anti-citrullinated antibody positive rheumatoid arthritis
with HLA-C*03:04 [15-21]. In this investigation we de-
scribe the first report of an association between the
HLA Class II molecule, HLA-DQB1*04:02, and patients
with PHFM. We also found a trend toward significance
with HLA-DQB1*03:02 and HLA-C*03:04. The HLA-
A*02 association from the 2000 study was not repli-
cated. When that study was performed, antibody-based
serotyping was used in which antibodies bind to the ex-
posed extra-cellular aspects of an HLA molecule [4].
This methodology can only define a group of HLA al-
leles, but not unique amino acid sequences, as can be
delineated by the PCR-based methods used in this
study. Since the advent of high-resolution four-digit
HLA genotyping, HLA-A*02 has been found to be a
commonly represented allele group (www.allelefre-
quencies.net), making the results of the 2000 study
likely a result of chance.
Multiple mechanisms have been proposed to explain the
association between HLA molecules and disease suscepti-
bility. Peptide motifs fit specifically into complementary
pockets on the HLA binding sites, thus determining which
Strock et al. BMC Infectious Diseases  (2015) 15:206 Page 4 of 5peptides will be presented to immune cells. A recent study
showed that abacavir binds inside the antigen-binding site
of HLA-B*57:01, allowing the presentation of peptides that
normally would not be able to bind, which could be per-
ceived as foreign by T-cells and trigger a response [12].
During T-cell development, antigen presentation by HLA
molecules helps with positive and negative selection, thus
determining which T-cells will survive and move into the
periphery, including possibly auto-reactive T-cells. Mo-
lecular mimicry between the epitope of the bound peptide
molecule and self-antigens could additionally lead to auto-
reactive T-cells or reactivation of silenced T-cells [22]. In a
recent study, Raychaudhuri et al. were able to show that
three specific single amino acid polymorphisms located
within the peptide-binding groove of HLA-DRB1 help ex-
plain the association between the HLA allele and risk of
anti-CCP rheumatoid arthritis [23]. Future work on the
association between HLA-DBQ1*04:02 and risk of PHFM
could attempt to identify similar amino acid polymor-
phisms with the peptide binding groove of the HLA Class
II molecule, and eventually help identify a specific patho-
genic auto-antigen that may lead to PHFM.
Other investigators recently reported immunopheno-
typing of mixed inflammatory cells infiltrating the medi-
astinal tissues of subjects with PHFM. They identified an
abundance of CD20+ B lymphocytes, which suggests
their possible immunopathogenic role [2]. This finding
is consistent with an HLA Class II molecule like HLA-
DBQ1*04:02 prompting a response from its presented
antigen by CD4+ Th2 helper cells. Th2 cytokines, such
as IL-4, IL-5, IL-13, and IL-21, provide paracrine signals
that activate myofibroblasts. B-cell activation stimulates
production of pro-fibrotic cytokines like IL-6 and possibly
autoantibodies. Activated macrophages and monocytes
produce TGF-β, which can directly activate mesenchymal
cells to transform into myofibroblasts and upregulate tran-
scription of genes like procollagen I & III via Smad protein
intermediates [24].
At this point therapeutic options for patients with
PHFM are extremely limited. Neither antifungal therapy
directed at H capsulatum nor anti-inflammatory therapy
with glucocorticoids have proven beneficial, although B
lymphocyte depletion with an agent such as rituximab
has been suggested as an alternative [1,2]. It is our hope
that further elucidation of the etiology underlying the
idiosyncratic inflammatory reaction believed to cause
PHFM may eventually lead to the development of novel
therapeutic approaches to patients with this condition.
Limitations
This study was limited by small sample size since PHFM
is a rare disease. With a larger sample, it is possible that
the associations seen between PHFM and both HLA-
DQB1*03:02 and HLA-C*03:04 would become statisticallysignificant. Additionally, past HLA association studies
have shown that ethnicity is an important part of the risk
associated with HLA type for a specific disease. The ideal
control group would be a large, regional Caucasian data-
base with HLA carriage frequencies available at the indi-
vidual level for statistical analysis. The NMDP control
cohort was restricted to those of “European American” an-
cestry; however, carriage frequencies were only available
for the group as a whole. On the other hand, the DCI con-
trol cohort was from Nashville and had individual carriage
frequencies available, but ethnicity was not reported. Since
the carriage frequencies between the two control cohorts
were not statistically different, this suggests that the lack
of ethnicity data from the DCI cohort did not affect the
results.
Conclusions
PHFM patients exhibit excessive fibrotic proliferation that
can auto-amputate major vessels and airways. In this in-
vestigation we describe the first report of an association
between HLA-DQB1*04:02 and patients with PHFM. An
HLA Class II association supports the premise that PHFM
patients carry an underlying idiosyncratic predisposition
that drives excessive fibrous proliferation when provoked
by exposure to H. capsulatum organisms.
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